This announcement is a separate document:
沛嘉醫療-B：自願性公告 - TaurusTrio經導管主動脈瓣置換系統多中心註冊臨床試驗於中國進行首例患者植入
PEIJIA-B: VOLUNTARY ANNOUNCEMENT - FIRST PATIENT IMPLANT IN MULTI-CENTER REGISTRATION CLINICAL TRIAL OF TaurusTrio TRANSCATHETER AORTIC VALVE REPLACEMENT SYSTEM IN CHINA
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.